Skip to main content
. 2022 Jan 19;13(2):2866–2877. doi: 10.1080/21655979.2021.2024970

Figure 4.

Figure 4.

4-PBA alleviated RFP-caused increase of AP2 and clathrin.

(a and b) HepG2 cells were treated by RFP (50 uM) and/or 4-PBA (1 mM) for 48 h. The mRNA and protein expressions of AP2 and clathrin in cells were tested via qRT-PCR and Western blotting. (c and d) Following CHOP-siRNA (or CHOP-plasmid) transfection and/or RFP (50 uM) or 4-PBA (1 mM) treatment for 48 h, the CHOP mRNA expression was tested via qRT-PCR assay and the protein expressions of AP2 and clathrin in HepG2 cells were tested via Western blotting. *P< 0.05, **P< 0.01, ***P< 0.001 vs. control group; #P< 0.05, ##P< 0.01, ###P< 0.001 vs. RFP group; &P< 0.05, &&&P< 0.001 vs. 4-PBA group.